UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

The EMBO journal, 1997-04, Vol.16 (7), p.1647-1655

1997

Volltextzugriff (PDF)

ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer

The EMBO journal, 1996-01, Vol.15 (2), p.254-264

1996

Volltextzugriff (PDF)

FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF‐23 signaling and regulating FGF‐23 expression in bone

Journal of bone and mineral research, 2011-10, Vol.26 (10), p.2486-2497

2011

Volltextzugriff (PDF)

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

Molecular and Cellular Biology, 1995-03, Vol.15 (3), p.1182-1191

1995

Volltextzugriff (PDF)

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2

Molecular and Cellular Biology, 1995-12, Vol.15 (12), p.6496-6505

1995

Volltextzugriff (PDF)

ErbB-1 and ErbB-2 Acquire Distinct Signaling Properties Dependent upon Their Dimerization Partner

Molecular and Cellular Biology, 1998-09, Vol.18 (9), p.5042-5051

1998

Volltextzugriff (PDF)

ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by ErbB Family Receptor Tyrosine Kinases

The Journal of cell biology, 2000-01, Vol.148 (2), p.385-397

2000

Volltextzugriff (PDF)

DISTINCT ROLES FOR LAMININ RECEPTORS IN THE DEVELOPMENT OF THE PERIPHERAL NERVOUS SYSTEM

Journal of the peripheral nervous system, 2002-03, Vol.7 (1), p.82-82

2002

Volltextzugriff (PDF)

beta 1-Class Integrins Regulate the Development of Laminae and Folia in the Cerebral and Cerebellar Cortex

Neuron (Cambridge, Mass.), 2001-08, Vol.31 (3), p.367-379

2001

Volltextzugriff (PDF)

αβ1 Integrins Are Required For Normal Peripheral Nerve Development

Journal of the peripheral nervous system, 2001-03, Vol.6 (1), p.48-48

2001

Volltextzugriff (PDF)

Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells

Cancer research (Chicago, Ill.), 1997-09, Vol.57 (17), p.3804-3811

1997

Volltextzugriff (PDF)

NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells

Oncogene, 1995-01, Vol.10 (1), p.167-175

1995

Volltextzugriff (PDF)

P3-17-11: Dovitinib (TKI258), a Dual Inhibitor of FGFR and VEGFR, Induces Tumor Growth Suppression in Xenograft Models of Primary Human Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P3-P3-17-11

2011

Volltextzugriff (PDF)

Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells

Molecular endocrinology (Baltimore, Md.), 1995-01, Vol.9 (1), p.14-23

1995

Volltextzugriff (PDF)

beta 1-Integrins Are Critical for Cerebellar Granule Cell Precursor Proliferation

The Journal of neuroscience, 2004-03, Vol.24 (13), p.3402-3412

2004

Volltextzugriff (PDF)

Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors

European journal of cell biology, 1996-06, Vol.70 (2), p.97-105

1996

Volltextzugriff (PDF)

Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells

Molecular endocrinology (Baltimore, Md.), 1995-01, Vol.9 (1), p.14-23

1995

Volltextzugriff (PDF)

Reelin, Disabled 1, and beta sub(1) integrins are required for the formation of the radial glial scaffold in the hippocampus

Proceedings of the National Academy of Sciences - PNAS, 2002-10, Vol.99 (20), p.13178-13183

2002

Volltextzugriff (PDF)

Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex

Neuron (Cambridge, Mass.), 2001-08, Vol.31 (3), p.367-379

2001

Volltextzugriff (PDF)

1014 Type I receptor tyrosine kinases as targets for cancer therapy

European journal of cancer (1990), 1995-11, Vol.31, p.S211-S211

1995

Volltextzugriff (PDF)

Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23‐mediated hypophosphatemic rickets

Journal of bone and mineral research, 2013-04, Vol.28 (4), p.899-911

2013

Volltextzugriff (PDF)

In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase

Cancer cell, 2004-03, Vol.5 (3), p.231-239

2004

Volltextzugriff (PDF)

Abstract CT326: Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.CT326-CT326

2014

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer

FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF‐23 signaling and regulating FGF‐23 expression in bone

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2

ErbB-1 and ErbB-2 Acquire Distinct Signaling Properties Dependent upon Their Dimerization Partner

ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by ErbB Family Receptor Tyrosine Kinases

DISTINCT ROLES FOR LAMININ RECEPTORS IN THE DEVELOPMENT OF THE PERIPHERAL NERVOUS SYSTEM

beta 1-Class Integrins Regulate the Development of Laminae and Folia in the Cerebral and Cerebellar Cortex

αβ1 Integrins Are Required For Normal Peripheral Nerve Development

Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells

NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells

P3-17-11: Dovitinib (TKI258), a Dual Inhibitor of FGFR and VEGFR, Induces Tumor Growth Suppression in Xenograft Models of Primary Human Breast Cancer

Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells

beta 1-Integrins Are Critical for Cerebellar Granule Cell Precursor Proliferation

Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors

Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells

Reelin, Disabled 1, and beta sub(1) integrins are required for the formation of the radial glial scaffold in the hippocampus

Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex

1014 Type I receptor tyrosine kinases as targets for cancer therapy

Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23‐mediated hypophosphatemic rickets

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations

In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase

Abstract CT326: Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors

Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study

Suchergebnisse filtern